edoc

Efficacy, tolerability and risk factors for virological failure of darunavir-based therapy for treatment-experienced HIV-infected patients : the Swiss HIV Cohort Study

Young, J. and Scherrer, A. U. and Günthard, H. F. and Opravil, M. and Yerly, S. and Böni, J. and Rickenbach, M. and Fux, C. A. and Cavassini, M. and Bernasconi, E. and Vernazza, P. and Hirschel, B. and Battegay, M. and Bucher, H. C. and Swiss HIV Cohort Study, . (2011) Efficacy, tolerability and risk factors for virological failure of darunavir-based therapy for treatment-experienced HIV-infected patients : the Swiss HIV Cohort Study. HIV medicine, Vol. 12, H. 5. pp. 299-307.

Full text not available from this repository.

Official URL: http://edoc.unibas.ch/dok/A6004736

Downloads: Statistics Overview

Abstract

Darunavir was designed for activity against HIV resistant to other protease inhibitors (PIs). We assessed the efficacy, tolerability and risk factors for virological failure of darunavir for treatment-experienced patients seen in clinical practice.
Faculties and Departments:03 Faculty of Medicine > Departement Klinische Forschung > Clinical Epidemiology and Biostatistics CEB > Klinische Epidemiologie (Bucher H)
03 Faculty of Medicine > Departement Biomedizin > Department of Biomedicine, University Hospital Basel > Infection Biology (Khanna)
UniBasel Contributors:Battegay, Manuel E. and Bucher, Heiner C.
Item Type:Article, refereed
Article Subtype:Research Article
Bibsysno:Link to catalogue
Publisher:Blackwell
ISSN:1464-2662
Note:Publication type according to Uni Basel Research Database: Journal article
Identification Number:
Last Modified:16 Aug 2013 07:34
Deposited On:16 Aug 2013 07:33

Repository Staff Only: item control page